Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) Institutional Ownership
CUSIP: 89455T109
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
113
Shares (Excl. Options)
35,835,404
Price
$2.45
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common stock, $0.001 par value
- Symbol
- TMCI on Nasdaq
- Shares outstanding
- 63,703,704
- Price per share
- $1.34
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 35,835,404
- Total reported value
- $87,924,395
- % of total 13F portfolios
- 0%
- Share change
- -3,936,723
- Value change
- -$21,906,721
- Number of holders
- 113
- Price from insider filings
- $1.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value is tracked under CUSIP 89455T109.
- 113 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 113 to 13 between Q4 2025 and Q1 2026.
- Reported value moved from $87,924,395 to $7,787,647.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 113 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 89455T109:
Significant Owners of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | 0% | $15,910,000 | +$120,000 | 6,364,000 | +0.76% | Armistice Capital, LLC | 31 Dec 2025 |
| GAGNON SECURITIES LLC | 9.6% | +55% | $15,355,268 | +$5,406,632 | 6,142,107 | +54% | Neil Gagnon | 31 Dec 2025 |
| MORGAN STANLEY | 3.4% | $13,931,448 | 2,091,809 | Morgan Stanley | 31 Dec 2024 | |||
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.8% | -67% | $2,863,745 | -$6,297,435 | 1,145,498 | -69% | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 113 institutional investors reported holding 35,835,404 shares of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI). This represents 56% of the company’s total 63,703,704 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | 6,364,000 | +0.76% | 0.38% | $15,591,800 |
| BlackRock, Inc. | 5.4% | 3,411,138 | -7.4% | 0% | $8,357,289 |
| GAGNON SECURITIES LLC | 4.9% | 3,110,575 | +38% | 1.6% | $7,620,909 |
| BANK OF AMERICA CORP /DE/ | 3.6% | 2,314,222 | +2594% | 0% | $5,669,845 |
| VANGUARD GROUP INC | 3.6% | 2,273,094 | -17% | 0% | $5,569,081 |
| Gagnon Advisors, LLC | 2.4% | 1,534,034 | +58% | 2.4% | $3,758,383 |
| MILLENNIUM MANAGEMENT LLC | 2.4% | 1,502,911 | -12% | 0% | $3,682,132 |
| CIBC Private Wealth Group LLC | 2.3% | 1,478,830 | -12% | 0.01% | $3,623,134 |
| First Eagle Investment Management, LLC | 2.3% | 1,462,983 | +18% | 0.01% | $3,584,308 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.8% | 1,145,498 | -68% | 0.01% | $2,806,470 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 1,144,372 | -0.18% | 0% | $2,804,163 |
| STATE STREET CORP | 1.6% | 994,191 | +0.24% | 0% | $2,435,768 |
| ACADIAN ASSET MANAGEMENT LLC | 1% | 662,785 | +144% | 0% | $1,620,000 |
| D. E. Shaw & Co., Inc. | 0.99% | 630,130 | -17% | 0% | $1,543,819 |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 0.93% | 589,617 | 0% | 1.4% | $1,444,562 |
| KOTLER KEVIN | 0.74% | 474,365 | 0% | 0.86% | $1,162,194 |
| NORTHERN TRUST CORP | 0.62% | 393,765 | -8.9% | 0% | $964,724 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.55% | 352,444 | -15% | 0% | $863,488 |
| GSA CAPITAL PARTNERS LLP | 0.55% | 347,755 | +213% | 0.07% | $852,000 |
| RAYMOND JAMES FINANCIAL INC | 0.51% | 322,942 | +828% | 0% | $791,208 |
| UBS Group AG | 0.46% | 293,929 | +3.7% | 0% | $720,126 |
| DIMENSIONAL FUND ADVISORS LP | 0.43% | 273,376 | +12% | 0% | $669,926 |
| DEUTSCHE BANK AG\ | 0.39% | 251,049 | -73% | 0% | $615,070 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.38% | 242,411 | -2.8% | 0% | $707,840 |
| Birchview Capital, LP | 0.36% | 226,947 | +28% | 0.33% | $556,020 |
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 5,811,611 | $7,787,647 | -$1,745,958 | $1.34 | 13 |
| 2025 Q4 | 35,835,404 | $87,924,395 | -$21,906,721 | $2.45 | 113 |
| 2025 Q3 | 38,823,239 | $260,292,697 | +$3,224,800 | $6.71 | 117 |
| 2025 Q2 | 38,411,285 | $225,932,843 | +$594,572 | $5.88 | 122 |
| 2025 Q1 | 37,892,233 | $314,933,438 | +$6,396,329 | $8.39 | 136 |
| 2024 Q4 | 37,307,543 | $277,767,394 | -$15,594,697 | $7.44 | 133 |
| 2024 Q3 | 39,629,299 | $229,799,434 | +$2,450,302 | $5.80 | 133 |
| 2024 Q2 | 39,705,068 | $264,072,594 | -$75,189,680 | $6.65 | 126 |
| 2024 Q1 | 41,245,049 | $537,228,351 | +$3,488,774 | $13.05 | 129 |
| 2023 Q4 | 41,010,068 | $522,886,552 | +$21,281,231 | $12.75 | 126 |
| 2023 Q3 | 39,193,648 | $513,809,790 | -$36,596,248 | $13.11 | 121 |
| 2023 Q2 | 38,926,750 | $995,556,262 | +$84,284,218 | $25.58 | 135 |
| 2023 Q1 | 35,535,142 | $895,139,591 | +$184,017,260 | $25.19 | 122 |
| 2022 Q4 | 26,874,663 | $617,852,430 | +$44,023,715 | $22.99 | 105 |
| 2022 Q3 | 26,104,333 | $576,118,458 | +$73,324,010 | $22.07 | 90 |
| 2022 Q2 | 23,108,213 | $331,376,313 | +$38,889,452 | $14.34 | 81 |
| 2022 Q1 | 20,370,513 | $385,285,843 | +$38,473,149 | $18.91 | 74 |
| 2021 Q4 | 17,228,093 | $320,930,460 | +$66,992,636 | $18.64 | 74 |
| 2021 Q3 | 13,036,758 | $350,676,095 | -$6,970,436 | $26.90 | 61 |
| 2021 Q2 | 13,009,799 | $406,683,468 | +$406,677,512 | $31.26 | 70 |
| 2021 Q1 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q4 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q3 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q2 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q1 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q4 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q3 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q2 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q1 | 179 | $6,000 | $33.52 | 1 |